Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Participants: 10
  • Start Date: February 2021
Use of Definity® Contrast Agent for Ultrasound of Intraocular Tumors
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Radiation, Biological
  • Participants: 36
  • Start Date: August 9, 2019
Phase II Randomized Trial of Stereotactic Radiotherapy (SRT) Followed by Intravitreal Aflibercept Injection for Patients With Ocular Melanoma
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 50
  • Start Date: July 26, 2018
Phase II Single-arm Multi-center Study of Adjuvant Ipilimumab in Combination With Nivolumab in Subjects With High-risk Ocular Melanoma
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 20
  • Start Date: April 16, 2018
Dexamethasone Intravitreal Implant for the Management of Exudative Retinal Detachment in Patients With Uveal Melanoma
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 3
  • Intervention Type: Combination Product
  • Participants: 102
  • Start Date: February 1, 2016
A Single-arm, Multi-Center, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients With Hepatic-Dominant Ocular Melanoma
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 2
  • Intervention Type: Radiation
  • Participants: 32
  • Start Date: November 2015
Phase II Trial, Randomized, Under Single-blind Conditions, Assessing Two Models of Modified Hypofractionated Proton-therapy on Patients With Large Choroidal Melanomas
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 2
  • Intervention Type: Drug, Other
  • Participants: 47
  • Start Date: July 31, 2013
Randomized Phase II Study Comparing the MET Inhibitor Cabozantinib to Temozolomide/Dacarbazine in Ocular Melanoma
Showing 1-12 of 17